CDKN2A and age-related macular degeneration: As AMD progresses, bioinformatics analyses have revealed a dynamic a shift in gene expression profiles, particularly toward pathways involved in angiogenesis (e.g., upregulation of VEGFA and HTRA1), lipid metabolism (APOE, ABCA1), and cellular senescence (CDKN2A).